Manufacturers Life Insurance Company, The Verastem, Inc. Transaction History

Manufacturers Life Insurance Company, The

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $77,335 - $138,748	-75,819 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$1.06 - $2.1 $80,368 - $159,219	75,819 New	75,819 $106,000
Q1 2022 May 20, 2022	SELL	$1.06 - $2.1 $16,196 - $32,088	-15,280 Reduced 16.77%	75,819 $107,000
Q4 2021 Feb 16, 2022	SELL	$2.05 - $3.2 $4,899 - $7,648	-2,390 Reduced 2.56%	91,099 $187,000
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $14,480 - $23,203	-5,701 Reduced 5.75%	93,489 $288,000
Q2 2021 Aug 12, 2021	SELL	$2.57 - $4.85 $13,109 - $24,739	-5,101 Reduced 4.89%	99,190 $404,000
Q1 2021 May 03, 2021	SELL	$1.9 - $2.82 $5,795 - $8,601	-3,050 Reduced 2.84%	104,291 $258,000
Q4 2020 Feb 12, 2021	BUY	$1.15 - $2.4 $10,406 - $21,717	9,049 Added 9.21%	107,341 $229,000
Q2 2020 Aug 10, 2020	BUY	$1.69 - $4.2 $166,113 - $412,826	98,292 New	98,292 $167,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $58,766 - $147,620	-47,013 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$2.79 - $4.09 $9,893 - $14,503	3,546 Added 8.16%	47,013 $139,000
Q4 2018 Feb 14, 2019	SELL	$3.23 - $7.01 $8,433 - $18,303	-2,611 Reduced 5.67%	43,467 $146,000
Q3 2018 Nov 14, 2018	BUY	$6.86 - $9.97 $28,016 - $40,717	4,084 Added 9.73%	46,078 $334,000
Q2 2018 Aug 14, 2018	BUY	$2.88 - $8.67 $115,528 - $347,788	40,114 Added 2133.72%	41,994 $289,000
Q1 2018 May 15, 2018	BUY	$2.92 - $3.81 $110 - $144	38 Added 2.06%	1,880 $6,000
Q4 2017 Feb 08, 2018	BUY	$2.99 - $4.85 $5,507 - $8,933	1,842	1,842 $6,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.